The Americas Clinical Chemistry Analyzer Market is Estimated to Reach $1,496.4 Million By 2019 A Report by …

(PRWEB) March 10, 2015

The Americas Clinical Chemistry Analyzers market is estimated to reach $1,496.4 million by 2019, at a CAGR of 5.2% from 2014 to 2019.

Clinical chemistry analyzers are the devices/instruments that read and analyze the fluid present in the human body. These fluids are considered to be one of the vital parts in a human body. The main function of the fluids is to connect plethora of cells to transport essential minerals such as vitamins and calcium in arteries and veins. The content of minerals in body fluids must be accurate in order to avoid diseases like hyponatremia.

Browse through the TOC of Americas Clinical Chemistry Analyzers market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures. http://www.micromarketmonitor.com/market/americas-clinical-chemistry-instruments-analyzer-2934211890.html

The major drivers of clinical chemistry analyzers market in America are increasing healthcare expenditure, increasing ageing population & prevalence rate of lifestyle diseases, rise in rental agreements and increasing medical insurances.

The percentage of Americans aging 65 and older remains high, at 25.9%, and one adult in ten has diabetes in North America. New figures indicate that the number of people living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030. In the North American and Caribbean regions in 2011, an estimated 37.7 million people were living with diabetes and this is expected to increase enormously in the coming years. The U.S., with an estimated 23.7 million people, has the highest number of people with diabetes followed by Mexico, and Canada. In 2012, 29.1 million Americans, or 9.3% of the population, had suffered from diabetes.

Make an inquiry @ http://www.micromarketmonitor.com/contact/2934211890-inquery_before_buy.html

In 2010, after adjusting for population age differences, hospitalization rates for heart attack were 1.8 times higher among adults aged 20 years or older with diagnosed diabetes, than among adults without diagnosed diabetes.

U.S. is the highest contributor to the Clinical Chemistry Analyzers market in America, as it accounted for 27.6% in 2014.

Speak to Analyst @ http://www.micromarketmonitor.com/contact/2934211890-speak_to_analyst.html

Read this article:
The Americas Clinical Chemistry Analyzer Market is Estimated to Reach $1,496.4 Million By 2019 A Report by ...